Defining research priorities in cystic fibrosis. Can existing knowledge and training in biomedical research affect the choice?


Journal

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
ISSN: 1873-5010
Titre abrégé: J Cyst Fibros
Pays: Netherlands
ID NLM: 101128966

Informations de publication

Date de publication:
05 2019
Historique:
received: 17 01 2018
revised: 22 02 2018
accepted: 22 02 2018
pubmed: 20 3 2018
medline: 15 8 2020
entrez: 20 3 2018
Statut: ppublish

Résumé

The aim of this report is to assess whether the research issues priorities are perceived differently according to the Stakeholders (SH)'s individual knowledge of research topics and degree of training in biomedical research. Four groups of SH were enrolled in this study: 1. Skilled SH, specifically trained in biomedicine; 2. Unskilled untrained SH who responded to a written questionnaire in 2015; 3. SH who were trained for one year in a course delivered by professionals; 4. Untrained SH who responded to an online questionnaire in 2017. The large ranking order variability observed among groups addresses the question that the choices are markedly influenced by the SH's backgrounds. Such results emphasize the need to consider the education level and the delivery of ad hoc training activities by professionals to broaden the base of SH who may be considered qualified to transfer the Patient Centered Outcome Research principles into practice.

Identifiants

pubmed: 29551462
pii: S1569-1993(18)30032-8
doi: 10.1016/j.jcf.2018.02.009
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

378-381

Informations de copyright

Copyright © 2018 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Auteurs

Roberto Buzzetti (R)

Epidemiologist, Bergamo, Italy.

Valeria Galici (V)

Cystic Fibrosis Center Florence, Italy.

Natalia Cirilli (N)

Cystic Fibrosis Centre, Mother-Child Department, United Hospitals, Ancona, Italy.

Fabio Majo (F)

Cystic Fibrosis Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Luigi Graziano (L)

Cystic Fibrosis Center Policlinico Umberto I, Rome, Italy, and Department of Public Health and Infectious Disease, Sapienza University of Rome, Italy.

Stefano Costa (S)

Cystic Fibrosis Center Messina, Italy.

Simona Bonacina (S)

Stakeholder, Milano, Italy.

Marila Carrubba (M)

Stakeholder, Siracusa, Italy.

Giuseppe Davì (G)

Stakeholder, Palermo, Italy.

Sabrina Gagliano (S)

Stakeholder, Catania, Italy.

Clizia Cazzarolli (C)

Physical Therapist, Cystic Fibrosis Centre, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Francesca Ficili (F)

Cystic Fibrosis Center Palermo, Italy.

Federico Alghisi (F)

Cystic Fibrosis Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Michele Samaja (M)

Stakeholder, Department of Health Science, University of Milan, Italy. Electronic address: michele.samaja@unimi.it.

Giuseppe Magazzù (G)

Cystic Fibrosis Center Messina, Italy; Department of Adult and Child Human Pathology, University of Messina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH